Rafferty Asset Management, LLC Ionis Pharmaceuticals Inc Transaction History

Rafferty Asset Management, LLC

$26.8 Billion
Q2 2024

A detailed history of Rafferty Asset Management, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 168,856 shares of IONS stock, worth $6.71 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

168,856

Previous 208,469 19.0%

Holding current value

$6.71 Million

Previous $9.04 Million 10.95%

% of portfolio

0.03%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$36.45 - $47.7 $1.44 Million - $1.89 Million	-39,613 Reduced 19.0%	168,856 $8.05 Million
Q1 2024 May 13, 2024	BUY	$42.03 - $53.55 $1.01 Million - $1.29 Million	24,073 Added 13.06%	208,469 $9.04 Million
Q4 2023 Feb 13, 2024	SELL	$43.39 - $51.63 $1.37 Million - $1.63 Million	-31,575 Reduced 14.62%	184,396 $9.33 Million
Q3 2023 Nov 13, 2023	BUY	$38.5 - $47.13 $445,945 - $545,906	11,583 Added 5.67%	215,971 $9.8 Million
Q2 2023 Aug 11, 2023	BUY	$34.73 - $43.33 $17,399 - $21,708	501 Added 0.25%	204,388 $8.39 Million
Q1 2023 May 11, 2023	SELL	$33.58 - $41.2 $506,789 - $621,790	-15,092 Reduced 6.89%	203,887 $7.29 Million
Q4 2022 Feb 13, 2023	BUY	$37.12 - $46.52 $2.49 Million - $3.12 Million	67,005 Added 44.09%	218,979 $8.27 Million
Q3 2022 Nov 14, 2022	BUY	$36.54 - $48.66 $1.19 Million - $1.59 Million	32,691 Added 27.41%	151,974 $6.72 Million
Q2 2022 Aug 12, 2022	SELL	$31.71 - $43.0 $1.89 Million - $2.56 Million	-59,511 Reduced 33.28%	119,283 $4.42 Million
Q1 2022 May 13, 2022	SELL	$29.88 - $37.04 $324,048 - $401,698	-10,845 Reduced 5.72%	178,794 $6.62 Million
Q4 2021 Feb 10, 2022	BUY	$25.61 - $35.1 $2.38 Million - $3.26 Million	92,902 Added 96.04%	189,639 $5.77 Million
Q3 2021 Nov 10, 2021	BUY	$33.54 - $40.55 $937,946 - $1.13 Million	27,965 Added 40.66%	96,737 $3.25 Million
Q2 2021 Aug 10, 2021	BUY	$34.54 - $47.25 $203,371 - $278,208	5,888 Added 9.36%	68,772 $2.74 Million
Q1 2021 May 10, 2021	BUY	$42.51 - $63.78 $1.81 Million - $2.71 Million	42,536 Added 209.04%	62,884 $2.83 Million
Q4 2020 Feb 10, 2021	SELL	$45.3 - $60.27 $807,744 - $1.07 Million	-17,831 Reduced 46.7%	20,348 $1.15 Million
Q3 2020 Nov 13, 2020	BUY	$47.45 - $62.95 $1.03 Million - $1.37 Million	21,695 Added 131.61%	38,179 $1.81 Million
Q2 2020 Aug 07, 2020	BUY	$46.85 - $61.05 $421,181 - $548,839	8,990 Added 119.96%	16,484 $972,000
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $2.29 Million - $3.48 Million	-54,943 Reduced 88.0%	7,494 $354,000
Q4 2019 Feb 10, 2020	SELL	$53.85 - $65.27 $1.92 Million - $2.33 Million	-35,726 Reduced 36.39%	62,437 $3.77 Million
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $1.08 Million - $1.32 Million	18,299 Added 22.91%	98,163 $5.88 Million
Q2 2019 Aug 09, 2019	BUY	$62.09 - $86.14 $588,426 - $816,348	9,477 Added 13.46%	79,864 $5.13 Million
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $3.72 Million - $5.71 Million	70,387 New	70,387 $5.71 Million

Others Institutions Holding IONS

# of Institutions

389

Shares Held

125M

Call Options Held

2.25M

Put Options Held

510K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Ionis Pharmaceuticals Inc Transaction History